Theravance (THRX) Reports Better-Than-Expected Q1 Loss of $0.31
THRX Hot Sheet
Revenue Growth %: +1,917.5%Financial Fact:
Interest expense: -1.5M
Today's EPS Names:
TARO, BRLI, TLB, More
Theravance Inc. (Nasdaq: THRX) reports Q1 loss of $0.31, 1 cent better than the analyst estimate of ($0.32). Revenue for the quarter was $9.5 million, versus the consensus of $7.6 million.
You May Also Be Interested In
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- Flowers Foods, Inc. (FLO) Reports In-Line Q1 EPS; Adjusts FY12 EPS Growth Outlook
- VeriFone Systems (PAY) Tops Q2 EPS by 3c; Guides Q3, FY12
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
